Dextran reduces surfactant inhibition by meconium

Area of Science:

• Pulmonary surfactant research
• Biomaterials science
• Neonatal respiratory distress syndrome

Background:

• Pulmonary surfactant is crucial for lung function.
• Meconium in the airways can inactivate surfactant, leading to respiratory distress.
• Dextran has shown protective effects against albumin inactivation of surfactant.

Purpose of the Study:

• To investigate the protective effect of dextran against meconium-induced inactivation of pulmonary surfactant.
• To evaluate the impact of dextran on the dynamic surface properties of surfactant in the presence of meconium.

Main Methods:

• Modified natural surfactant (Curosurf) mixtures with meconium and dextran were prepared.
• Dynamic surface properties were assessed using the pulsating bubble technique.
• Surface adsorption time, minimum surface tension (gammamin), and maximum surface tension (gammamax) were measured.

Main Results:

• Dextran addition shortened Curosurf adsorption time.
• Meconium significantly increased both gammamin and gammamax.
• Dextran dose-dependently reduced meconium-induced increases in gammamin and gammamax.
• Significant negative correlations were found between dextran concentration and both gammamin and gammamax.

Conclusions:

• Dextran effectively reduces surfactant inhibition by meconium.
• The protective effect of dextran is dose-dependent.
• Dextran shows potential as a therapeutic agent to mitigate meconium-induced lung injury.